Fulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation | ||||
Medical Journal of Viral Hepatitis | ||||
Article 3, Volume 7.1, Issue 1, December 2022, Page 13-14 PDF (151.64 K) | ||||
Document Type: Original article | ||||
DOI: 10.21608/mjvh.2022.279332 | ||||
View on SCiNiTO | ||||
Authors | ||||
Antonio Mastroianni1; Sonia Greco2; Maria Vittoria Mauro3; Roberto Manfredi 4 | ||||
1Department of Infectious Diseases, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy | ||||
2Department of Infectious Diseases, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy. | ||||
3Department of Microbiology, Annunziata-Mariano Santo-S. Barbara Hospital, Cosenza, Italy. | ||||
4Dept of Infectious Diseases, University of Bologna, S. Orsola Hospital | ||||
Abstract | ||||
Background: A severe, near-fatal liver failure due to a concomitant acute HBV-HCV infection has been controlled and later fully resolved from a clinical and a virological point of view, by a prompt and appropriate antiviral treatment. | ||||
Keywords | ||||
Fulminant hepatitis; concomitant HBV-HCV infection; entecavir; sofosbuvir-velpatasvir; favorable outcome | ||||
Statistics Article View: 121 PDF Download: 206 |
||||